MedFirst Healthcare Services, Inc. (TPEX:4175)
48.20
-1.40 (-2.82%)
Nov 20, 2026, 1:30 PM CST
TPEX:4175 Revenue
MedFirst Healthcare Services had revenue of 2.02B TWD in the quarter ending September 30, 2026, with 1.44% growth. This brings the company's total for the last twelve months to 8.09B, up 1.86% year-over-year. In the year 2025, MedFirst Healthcare Services had annual revenue of 8.01B with 3.60% growth. That makes MedFirst Healthcare Services the 16,003rd largest company in the world by revenue and 552nd in Taiwan.
Revenue (ttm)
8.09B
Revenue Growth
+1.86%
P/S Ratio
0.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.04B
Revenue by Geography
- Taiwan 8.23B 97.5%
- Mainland China 209.59M 2.5%
Fiscal year ended Dec 31, 2025 See the full TPEX:4175 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.01B | 278.57M | 3.60% |
| Dec 31, 2024 | 7.73B | 287.90M | 3.87% |
| Dec 31, 2023 | 7.45B | 222.11M | 3.07% |
| Dec 31, 2022 | 7.22B | 683.79M | 10.46% |
| Dec 31, 2021 | 6.54B | 612.84M | 10.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 24.62B |
| Syngen Biotech | 2.05B |
| Dynamic Medical Technologies | 1.42B |
| BIONET | 1.32B |
| Chunghwa Chemical Synthesis & Biotech | 997.80M |
| Applied BioCode | 728.39M |
| GlycoNex Incorporation | 19.51M |
| Caliway Biopharmaceuticals | 15.98M |